This Week at FDA: Lawmakers Look to Fund FDA, HHS’ Shutdown RIF, and MoreOctober 16, 2025October 18, 2025
This Week at FDA: More Layoffs at HHS, Prasad’s CBER Hires, and Peter Marks Joins Eli LillyOctober 10, 2025October 14, 2025
This Week at FDA: ANDA Prioritization Pilot, CDRH Guidance Priorities, and MoreOctober 3, 2025October 4, 2025
This Week: FDA Revokes LDT Rule, Monarez Warns About Vaccine Policies, Kennedy Called to Defend His DecisionsSeptember 19, 2025September 19, 2025
This Week at FDA: FDA’s Ad Crackdown, Abandoning AdComms, and MoreSeptember 12, 2025September 15, 2025
This Week at FDA: FDA to Scrutinize Co-Administered Vaccines, New CRLs, and a GLP-1 ‘Green List’September 5, 2025September 15, 2025
This Week at FDA: CDC Director Fired, FDA Advances New MASH Tool, CMC Pilot ExtendedAugust 29, 2025September 3, 2025
This Week at FDA: Investigation Reveals Extent of HHS RIFs, Makary Updates on CNPV Pilot, FDA to Hold Meeting on User FeesAugust 22, 2025August 26, 2025
FDA Cites Firms for CGMP Violations, Unapproved Products, and Device Reporting IssuesAugust 19, 2025August 26, 2025
